Translational and Therapeutic Approaches to the Understanding and Treatment of Dyslipidemia

Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):e56-61. doi: 10.1161/ATVBAHA.116.307808.
No abstract available

Keywords: PCSK9 protein; cardiovascular diseases; cholesterol; cholesterol, HDL; lipids; lipoproteins.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biological Transport
  • Cholesterol / blood
  • Cholesterol Ester Transfer Proteins / antagonists & inhibitors
  • Cholesterol, HDL / administration & dosage
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Dietary Supplements
  • Dyslipidemias / blood
  • Dyslipidemias / drug therapy*
  • Gain of Function Mutation
  • Humans
  • Hypolipidemic Agents / pharmacology
  • Hypolipidemic Agents / therapeutic use*
  • Liver X Receptors / agonists
  • Niacin / therapeutic use
  • Oligoribonucleotides, Antisense / therapeutic use
  • Proprotein Convertase 9 / antagonists & inhibitors
  • Proprotein Convertase 9 / blood
  • Proprotein Convertase 9 / genetics
  • Recombinant Proteins / administration & dosage

Substances

  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hypolipidemic Agents
  • Liver X Receptors
  • NR1H3 protein, human
  • Oligoribonucleotides, Antisense
  • Recombinant Proteins
  • Niacin
  • Cholesterol
  • PCSK9 protein, human
  • Proprotein Convertase 9